BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31527148)

  • 41. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions.
    McKeirnan KC; Garrelts MacLean L
    J Am Pharm Assoc (2003); 2018; 58(6):599-607. PubMed ID: 30266565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients' knowledge of new medicines after discharge from hospital: What are the effects of hospital-based discharge counseling and community-based medicines use reviews (MURs)?
    Elson R; Cook H; Blenkinsopp A
    Res Social Adm Pharm; 2017; 13(3):628-633. PubMed ID: 27283244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
    Bryant LJ; Coster G; Gamble GD; McCormick RN
    Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacist as educator and storyteller.
    Ponte CD
    Diabetes Educ; 2002; 28(5):682-5. PubMed ID: 14625955
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacy-based management of influenza: lessons learned from research.
    Klepser ME; Adams AJ
    Int J Pharm Pract; 2018 Dec; 26(6):573-578. PubMed ID: 30265414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist.
    Foubert K; Mehuys E; Claes L; Van Den Abeele D; Haems M; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2019 Oct; 74(5):326-333. PubMed ID: 30235081
    [No Abstract]   [Full Text] [Related]  

  • 53. Revealing undetected problems with medication therapy management services.
    Alexander AJ; Gatewood SB
    Consult Pharm; 2008 Jun; 23(6):473-6. PubMed ID: 18764677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
    van Eikenhorst L; Salema NE; Anderson C
    Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of targeted medication reviews to deliver preconception care: A demonstration project.
    DiPietro Mager NA; Bright DR; Markus D; Weis L; Hartzell DM; Gartner J
    J Am Pharm Assoc (2003); 2017; 57(1):90-94.e1. PubMed ID: 27838391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Columbus Air Force Base medication profile intervention practice innovation.
    Guill JV; Griffin LA; Goodwin TD
    J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innovative Community Pharmacy Practice Models in North Carolina.
    Hemberg N; Huggins D; Michaels N; Moose J
    N C Med J; 2017; 78(3):198-201. PubMed ID: 28576962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.